This inventor holds 23 USPTO granted patents and 18 published patent applications and 5 EPO patents, primarily in Cancer Therapeutics. Top assignees: Accutar Biotechnology Inc., Tiger Biotherapeutics Inc.. Active years: 2018-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- New York, NY (US) (2018 - 2022)
- Brooklyn, NY (US) (2019 - 2023)
Company Filing History:
Years Active: 2018-2025
Areas of Expertise:
Title: Jie Fan: Innovative Inventor and Patent Holder
Introduction:
Jie Fan, a remarkable inventor and patent holder, has made significant contributions in the field of pharmaceuticals and cancer therapeutics. Hailing from New York, NY, Jie Fan has garnered attention with his prolific inventiveness and numerous patents. This article will delve into his latest patents, career highlights, collaborations, and ultimate dedication to advancing medical science.
Latest Patents:
With a total of 18 patents to his name, Jie Fan continues to push the boundaries of medical research. Two of his recent patents include "Combinations of estrogen receptor degraders and cyclin-dependent kinase inhibitors for treating cancer" and "Substituted quinoline-8-carbonitrile derivatives with androgen receptor degradation activity and uses thereof." These groundbreaking patents showcase Jie Fan's pioneering work in developing novel compounds and pharmaceutical compositions for the prevention and treatment of cancer.
Career Highlights:
Jie Fan has consistently demonstrated an exceptional ability to translate scientific knowledge into practical applications. His patents highlight his expertise in designing compounds with specific receptor degradation activity, such as estrogen receptor degraders and androgen receptor degraders. These innovations have the potential to revolutionize cancer treatment strategies and improve patient outcomes.
Accutar Biotechnology Inc.:
Jie Fan is an esteemed member of the research and development team at Accutar Biotechnology Inc. This renowned biotech company is at the forefront of innovative medical research, making significant contributions to the field. Jie Fan's association with Accutar Biotechnology Inc. demonstrates his commitment to collaborating with leading industry players to drive advancements in the fight against cancer.
Collaborations:
Innovation thrives when brilliant minds come together, and Jie Fan understands the importance of collaboration in creating groundbreaking inventions. Among his esteemed colleagues are Ke Liu and Wei He, who equally contribute to the success of their projects. Their collective efforts enhance the progress in designing effective cancer therapeutics, fostering a collaborative environment that encourages creativity and synergy.
Conclusion:
Jie Fan's remarkable journey as an inventor and patent holder exemplifies his unwavering dedication to fighting cancer through innovative pharmaceutical approaches. His latest patents demonstrate a deep understanding of receptor degradation activity, paving the way for new treatments and advancements in cancer therapies. Collaborating with Accutar Biotechnology Inc. and talented colleagues further strengthens Jie Fan's impact, expanding the possibilities of cancer treatment. As Jie Fan continues to push boundaries and make significant contributions, his work undoubtedly remains instrumental in shaping the future of cancer research and therapeutics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile